A Review: The Antiviral Activity of Cyclic Peptides

Overview

Journal Int J Pept Res Ther

Publisher Springer

Date 2022 Dec 6

PMID 36471676

Authors

Le Yi Chia

Palanirajan Vijayaraj Kumar

Marwan Abdelmahmoud Abdelkarim Maki

Guna Ravichandran

Sivasudha Thilagar

Affiliations

Soon will be listed here.

Abstract

Graphical Abstract:

Citing Articles

Influence of heterochirality on the structure, dynamics, biological properties of cyclic(PFPF) tetrapeptides obtained by solvent-free ball mill mechanosynthesis.

Bak-Sypien I, Pawlak T, Paluch P, Wroblewska A, Dolot R, Pawlowicz A Sci Rep. 2024; 14(1):12825.

PMID: 38834643 PMC: 11150477. DOI: 10.1038/s41598-024-63552-4.

Identification and Characterization of CC-AMP1-like and CC-AMP2-like Peptides in spp.

Culver K, Sadecki P, Jackson J, Brown Z, Hnilica M, Wu J J Proteome Res. 2024; 23(8):2948-2960.

PMID: 38367000 PMC: 11296913. DOI: 10.1021/acs.jproteome.3c00597.

Development and Challenges of Cyclic Peptides for Immunomodulation.

Jiang X, Gao L, Li Z, Shen Y, Lin Z Curr Protein Pept Sci. 2023; 25(5):353-375.

PMID: 37990433 DOI: 10.2174/0113892037272528231030074158.

Mixture-Based Screening of Focused Combinatorial Libraries by NMR: Application to the Antiapoptotic Protein hMcl-1.

Alboreggia G, Udompholkul P, Baggio C, Pellecchia M J Med Chem. 2023; 66(14):10108-10118.

PMID: 37464766 PMC: 10388297. DOI: 10.1021/acs.jmedchem.3c01073.

Native and Engineered Cyclic Disulfide-Rich Peptides as Drug Leads.

Tyler T, Durek T, Craik D Molecules. 2023; 28(7).

PMID: 37049950 PMC: 10096437. DOI: 10.3390/molecules28073189.

References

Lu Z, Wagoner R, Harper M, Baker H, Hooper J, Bewley C . Mirabamides E-H, HIV-inhibitory depsipeptides from the sponge Stelletta clavosa. J Nat Prod. 2011; 74(2):185-93. PMC: 3072293. DOI: 10.1021/np100613p. View

August A, Attarwala H, Himansu S, Kalidindi S, Lu S, Pajon R . A phase 1 trial of lipid-encapsulated mRNA encoding a monoclonal antibody with neutralizing activity against Chikungunya virus. Nat Med. 2021; 27(12):2224-2233. PMC: 8674127. DOI: 10.1038/s41591-021-01573-6. View

Wang W, Owen S, Rudolph D, Cole A, Hong T, Waring A . Activity of alpha- and theta-defensins against primary isolates of HIV-1. J Immunol. 2004; 173(1):515-20. DOI: 10.4049/jimmunol.173.1.515. View

Hamamoto I, Harazaki K, Inase N, Takaku H, Tashiro M, Yamamoto N . Cyclosporin A inhibits the propagation of influenza virus by interfering with a late event in the virus life cycle. Jpn J Infect Dis. 2013; 66(4):276-83. DOI: 10.7883/yoken.66.276. View

Wen Y, Golubkov V, Strongin A, Jiang W, Reed J . Interaction of hepatitis B viral oncoprotein with cellular target HBXIP dysregulates centrosome dynamics and mitotic spindle formation. J Biol Chem. 2007; 283(5):2793-803. DOI: 10.1074/jbc.M708419200. View

Khachatoorian R, Ruchala P, Waring A, Jung C, Ganapathy E, Wheatley N . Structural characterization of the HSP70 interaction domain of the hepatitis C viral protein NS5A. Virology. 2014; 475:46-55. PMC: 4284078. DOI: 10.1016/j.virol.2014.10.011. View

Madan V, Bartenschlager R . Structural and Functional Properties of the Hepatitis C Virus p7 Viroporin. Viruses. 2015; 7(8):4461-81. PMC: 4576187. DOI: 10.3390/v7082826. View

Tambunan U, Alkaff A, Nasution M, Parikesit A, Kerami D . Screening of commercial cyclic peptide conjugated to HIV-1 Tat peptide as inhibitor of N-terminal heptad repeat glycoprotein-2 ectodomain Ebola virus through in silico analysis. J Mol Graph Model. 2017; 74:366-378. DOI: 10.1016/j.jmgm.2017.04.001. View

Bulet P, Stocklin R, Menin L . Anti-microbial peptides: from invertebrates to vertebrates. Immunol Rev. 2004; 198:169-84. DOI: 10.1111/j.0105-2896.2004.0124.x. View

10.

Sattely E, Fischbach M, Walsh C . Total biosynthesis: in vitro reconstitution of polyketide and nonribosomal peptide pathways. Nat Prod Rep. 2008; 25(4):757-93. DOI: 10.1039/b801747f. View

11.

Jakubiec-Krzesniak K, Rajnisz-Mateusiak A, Guspiel A, Ziemska J, Solecka J . Secondary Metabolites of Actinomycetes and their Antibacterial, Antifungal and Antiviral Properties. Pol J Microbiol. 2018; 67(3):259-272. PMC: 7256786. DOI: 10.21307/pjm-2018-048. View

12.

Choi J, Joo S . Recent Trends in Cyclic Peptides as Therapeutic Agents and Biochemical Tools. Biomol Ther (Seoul). 2019; 28(1):18-24. PMC: 6939695. DOI: 10.4062/biomolther.2019.082. View

13.

Alhoot M, Rathinam A, Wang S, Manikam R, Sekaran S . Inhibition of dengue virus entry into target cells using synthetic antiviral peptides. Int J Med Sci. 2013; 10(6):719-29. PMC: 3638295. DOI: 10.7150/ijms.5037. View

14.

Vilas Boas L, Campos M, Berlanda R, de Carvalho Neves N, Franco O . Antiviral peptides as promising therapeutic drugs. Cell Mol Life Sci. 2019; 76(18):3525-3542. PMC: 7079787. DOI: 10.1007/s00018-019-03138-w. View

15.

Hoffmann A, Guha S, Wu E, Ghimire J, Wang Y, He J . Broad-Spectrum Antiviral Entry Inhibition by Interfacially Active Peptides. J Virol. 2020; 94(23). PMC: 7654261. DOI: 10.1128/JVI.01682-20. View

16.

Frederico de Carvalho Dominguez Souza B, Drexler J, Lima R, Rosario M, Martins Netto E . Theories about evolutionary origins of human hepatitis B virus in primates and humans. Braz J Infect Dis. 2014; 18(5):535-43. PMC: 9428206. DOI: 10.1016/j.bjid.2013.12.006. View

17.

Al Shaer D, Al Musaimi O, Albericio F, de la Torre B . 2019 FDA TIDES (Peptides and Oligonucleotides) Harvest. Pharmaceuticals (Basel). 2020; 13(3). PMC: 7151716. DOI: 10.3390/ph13030040. View

18.

Penberthy W, Chari S, Cole A, Cole A . Retrocyclins and their activity against HIV-1. Cell Mol Life Sci. 2011; 68(13):2231-42. PMC: 4511374. DOI: 10.1007/s00018-011-0715-5. View

19.

Owen S, Rudolph D, Wang W, Cole A, Waring A, Lal R . RC-101, a retrocyclin-1 analogue with enhanced activity against primary HIV type 1 isolates. AIDS Res Hum Retroviruses. 2004; 20(11):1157-65. DOI: 10.1089/aid.2004.20.1157. View

20.

Garrus J, von Schwedler U, Pornillos O, Morham S, Zavitz K, Wang H . Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding. Cell. 2001; 107(1):55-65. DOI: 10.1016/s0092-8674(01)00506-2. View